| Literature DB >> 31308110 |
Abstract
The use of multiple medications is common in palliative care, putting patients at risk of adverse events and a high tablet burden. Deprescribing is the process of reviewing and stopping potentially inappropriate medications in order to improve quality of life. Barriers to deprescribing exist meaning many patients will take multiple medications despite being in the final months of life. The OncPal deprescribing guideline is a useful tool to support the process for patients with a limited life expectancy. There is evidence for the safety of stopping certain medications, particularly those aimed at primary prevention. A systematic process of reviewing individual medications and their appropriateness is recommended. © Royal College of Physicians 2019. All rights reserved.Entities:
Keywords: OncPal deprescribing guideline; Polypharmacy; deprescribing; medication review
Year: 2019 PMID: 31308110 PMCID: PMC6752237 DOI: 10.7861/clinmedicine.19-4-311
Source DB: PubMed Journal: Clin Med (Lond) ISSN: 1470-2118 Impact factor: 2.659